Two Johns Hopkins researchers race to bring a drug to market that holds promise for millions afflicted with the devastating cognitive disorder
/ Johns Hopkins Magazine
The development of experimental Ebola drug ZMapp has its experimental roots in the lab of Johns Hopkins biophysicist Richard Cone.
/ Johns Hopkins Magazine